Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Prokineticin Receptor 1 Antibodies:
anti-Human Prokineticin Receptor 1 Antibodies:
anti-Rat (Rattus) Prokineticin Receptor 1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal Prokineticin Receptor 1 Primary Antibody for FACS, IHC - ABIN347055
Brouillet, Murthi, Hoffmann, Salomon, Sergent, De Mazancourt, Dakouane-Giudicelli, Dieudonné, Rozenberg, Vaiman, Barbaux, Benharouga, Feige, Alfaidy: EG-VEGF controls placental growth and survival in normal and pathological pregnancies: case of fetal growth restriction (FGR). in Cellular and molecular life sciences : CMLS 2013
Show all 5 Pubmed References
Found evidence for kidney and liver cystic phenotypes in the Carney complex, a tumoral syndrome caused by mutations in PRKAR1A (show PRKAR1A Antibodies).
Data suggest that introduction of cGMP-specific (show PDE6A Antibodies) residues using site-directed mutagenesis reduces selectivity of cyclic nucleotide-binding domain (CNBD) of PRKAR1A (show PRKAR1A Antibodies); combination of two mutations (G316R/A336T) results in a cGMP-selective binding site in the C-terminal CNBD; introduction of corresponding mutations (T192R/A212T) into the N-terminal CNBD results in a highly cGMP-selective binding site.
Data show that ELOVL7 (show ELOVL7 Antibodies), SOCS3 (show SOCS3 Antibodies), ACSL4 (show ACSL4 Antibodies) and CLU (show CLU Antibodies) were upregulated while PRKAR1A (show PRKAR1A Antibodies) and ABCG1 (show ABCG1 Antibodies) were downregulated in the phlegm-dampness group.
Electrostatic interactions are mediators in the allosteric activation of protein kinase A RIalpha (show PRKAR1A Antibodies).
the present study reported for the first time an intronic splice site mutation in the PRKAR1A (show PRKAR1A Antibodies) gene of a Chinese family with Carney complex, which probably caused skin pigmentation observed in affected family members.
This study reports a novel point mutation of the PRKAR1A (show PRKAR1A Antibodies) gene in a patient with Carney complex who presented with significant osteoporosis and fractures.
a significant association between PKR2 rs6053283 polymorphism and Recurrent pregnancy loss (RPL)(P=0.003), whereas no association was observed between PKR1 rs4627609 polymorphism and RPL (P=0.929) in the Chinese Han population.
Letter/Case Report: novel PRKAR1A (show PRKAR1A Antibodies) mutation resulting in a splicing variant in a case of Carney complex.
Data suggest that prokineticins (PROK1 (show Prok1 Antibodies) and PROK2 (show PROK2 Antibodies)) and prokineticin receptors (PROKR1 and PROKR2 (show PROKR2 Antibodies)) act as main regulators of physiological functions of ovary, uterus, placenta, and testis. [REVIEW]
EG-VEGF (show Prok1 Antibodies) and its receptor PKR1 might play a role in the pathogenesis of adrenocortical tumors and could serve as prognostic markers for this rare malignant disease.
These results establish PKR1 via NFATc3 (show NFATC3 Antibodies) as a crucial modifier of mesenchymal-epithelial transition processing to the development of nephron.
show that MRAP2 significantly and specifically inhibits PKR1 signaling.
Data show that the prokineticins and their receptors PROK2 (show PROK2 Antibodies), PKR1 and PKR2 (show PROKR2 Antibodies) contributes to altered sensitivity in diabetic neuropathy and its inhibition blocked both allodynia and inflammatory events underlying disease.
These results suggest PKR1 to be a crucial player in the preadipocyte proliferation and differentiation.
Loss of PKR1 causes renal and cardiac structural and functional changes because of deficits in survival signaling, mitochondrial, and progenitor cell functions in found both organs.
The functional characteristics of coronary endothelial cells depend on the expression of PKR1 and PKR2 (show PROKR2 Antibodies) levels and the divergent signaling pathways used by these receptors.
Identification and molecular characterization of two closely related G protein-coupled receptors (prokineticin receptor)
PKR1 protein was localised to the labyrinth layer and showed the same pattern of expression as EG-VEGF (show Prok1 Antibodies) in mouse placenta.
Cardiomyocyte-PKR1 signaling upregulates its own ligand prokineticin-2 (show PROK2 Antibodies) that acts as a paracrine factor, triggering epicardial-derived progenitor cell proliferation/differentiation.
Data show that the inflammation-induced up-regulation of PK2 (show PROK2 Antibodies) was significantly less in pkr1 null mice than in WT and pkr2 (show PROKR2 Antibodies) null mice, demonstrating a role of PKR1 in setting PK2 (show PROK2 Antibodies) levels during inflammation.
PROK1 (show Prok1 Antibodies), acting via PROKR1, may be involved in the recruitment of monocytes to regressing CL and atretic follicles and their consequent activation therein.
G protein-coupled receptor for prokineticin
G protein-coupled receptor 73
, G-protein coupled receptor 73
, G protein-coupled receptor ZAQ
, G-protein coupled receptor ZAQ
, prokineticin receptor 1
, prokineticin receptor 1-like